Titan Treats First Parkinson’s Patient with Ropinirole Implant in Clinical Trial — Fun Health

No comments

The first patient has been treated in a clinical trial evaluating Titan Pharmaceuticals’ ropinirole implants, designed to treat the signs and symptoms of Parkinson’s disease. The Phase 1/2 study (NCT03250117) is taking place at three clinical sites in the U.S. that specialize in Parkinson’s research. Researchers expect to enroll 20 Parkinson’s patients who are currently taking oral ropinirole (Requip, manufactured by…

via Titan Treats First Parkinson’s Patient with Ropinirole Implant in Clinical Trial — Fun Health

Leave a Reply